Survivin – biology and potential as a therapeutic target in oncology

Overview of attention for article published in OncoTargets and therapy, October 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 127 Dimensions

Readers on

mendeley: 112 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 127 publications that cite this research output.

127

The most recent citing publications are shown below. View all 127 publications that cite this research output on Dimensions.

Interaction of SMAC/Diablo with a survivin/BIRC5-derived peptide alters essential cancer hallmarks: tumor growth, inflammation, and immunosuppression

Article in Molecular Therapy (April 2024)

Ethanolic extract of Euphorbia gypsicola induces differentiation and apoptosis in human myeloid leukemia K562 cells

Article in European Journal of Integrative Medicine (April 2024)

Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients

Article in Egyptian Rheumatology and Rehabilitation (October 2023)